<code id='364589EAA9'></code><style id='364589EAA9'></style>
    • <acronym id='364589EAA9'></acronym>
      <center id='364589EAA9'><center id='364589EAA9'><tfoot id='364589EAA9'></tfoot></center><abbr id='364589EAA9'><dir id='364589EAA9'><tfoot id='364589EAA9'></tfoot><noframes id='364589EAA9'>

    • <optgroup id='364589EAA9'><strike id='364589EAA9'><sup id='364589EAA9'></sup></strike><code id='364589EAA9'></code></optgroup>
        1. <b id='364589EAA9'><label id='364589EAA9'><select id='364589EAA9'><dt id='364589EAA9'><span id='364589EAA9'></span></dt></select></label></b><u id='364589EAA9'></u>
          <i id='364589EAA9'><strike id='364589EAA9'><tt id='364589EAA9'><pre id='364589EAA9'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:759
          Illustration of a doctor and patient. The shadow behind the doctor displays 0s and 1s for artificial intelligence. –– health tech coverage from STAT
          Molly Ferguson for STAT

          The world’s largest technology companies are racing to build generative AI into every corner of health and medicine.

          Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients. Not to be outdone, Amazon has unveiled a service to help build clinical note scribes, and is separately working to embed generative AI in drug research and development.

          advertisement

          All of this has unfolded faster than federal regulators could blink — or answer questions about how the technology should be tested and evaluated, whether it will help or hurt patients, and how it will impact privacy and the use of personal data.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Biogen Alzheimer’s drug launch off to slow start
          Biogen Alzheimer’s drug launch off to slow start

          Illustration:AlexHogan/STAT;Photo:EisaiviaAPSevenmonthsafterUSdrugregulatorsfullyapprovedBiogen’stre

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Insurer loopholes limit power of law against surprise medical bills

          AdobeYou’rereadingthewebversionofHealthCareInc., STAT’sweeklynewsletter followingtheflowofmoneyinmed